CANF Can-Fite Biopharma Ltd
$2.33▲ +7.87%
Healthcare
Other
After hours
$2.33▲ +0.00%
Sep 11, 6:57 PM ET
Volume 152.7K
Avg Volume (10D) 2.12M
Key Metrics & Fundamentals
Market Cap
$4.99M
P/E Ratio
–
Div Yield
–%
52W Range
2.16 - 13.40
% vs 50 MA
-26.93%
% vs 200 MA
-38.50%
RSI-14
32.7
MACD Histogram
-0.1100
Beta (1Y vs SPY)
0.77
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation
GlobeNewswire · Sep 9, 2026 11:00 AM
Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
GlobeNewswire · Sep 8, 2026 12:20 PM
Top Midday Decliners
MT Newswires · Sep 2, 2026 6:03 PM
Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study
Benzinga · Sep 2, 2026 3:48 PM
Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds
GlobeNewswire · Sep 2, 2026 1:02 PM
Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
GlobeNewswire · Sep 2, 2026 11:00 AM
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer
GlobeNewswire · Aug 17, 2026 11:00 AM
Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates
GlobeNewswire · Aug 12, 2026 11:00 AM
Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome
GlobeNewswire · Aug 3, 2026 11:00 AM
Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World's Premier Scientific Meetings in Oncology
GlobeNewswire · Jul 20, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for CANF.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.